Company Filing History:

7 out of 4,455

Pfizer Corporation

patents

4 out of 523

Pharmacia & Upjohn Company

Years Active: 2002-2012

Loading Chart...

12 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 8318762 - Pyrazolospiroketone acetyl-CoA carboxylase inhibitors (2012-11-27),

2. 7250418 - [object Object] (2007-07-31),

3. 7087617 - Substituted pyrimidine derivatives (2006-08-08),

4. 7041672 - Substituted aryl 1, 4-pyrazine derivatives (2006-05-09),

5. 7015229 - Substituted pyrimidinones and pyrimidinthiones (2006-03-21),

6. 6992087 - Substituted aryl 1,4-pyrazine derivatives (2006-01-31),

7. 6964965 - Substituted pyrazine derivatives (2005-11-15),

8. 6849620 - N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease (2005-02-01),

9. 6599916 - Quinuclidine-substituted heteroaryl moieties for treatment of disease (2003-07-29),

10. 6562816 - Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease (2003-05-13),

11. 6500840 - Quinuclidine-substituted heteroaryl moieties for treatment of disease (2002-12-31),

12. 6492385 - Quinuclidine-substituted heteroaryl moieties for treatment of disease (2002-12-10),

Title: The Innovations of Inventor Jeffrey W Corbett

Introduction

Jeffrey W Corbett, based in Portage, MI, has made significant contributions to the field of pharmaceutical innovation, holding a total of 12 patents. His inventive work focuses on the development of compounds that target specific biological processes, aiming to provide therapeutic solutions for various health conditions.

Latest Patents

Among his latest patents is the invention pertaining to Pyrazolospiroketone acetyl-CoA carboxylase inhibitors. This innovation introduces compounds of Formula (1) or their pharmaceutically acceptable salts, demonstrating effectiveness in treating diseases linked to the inhibition of the acetyl-CoA carboxylase enzyme. Additionally, Corbett has developed compounds that act as CRF receptor antagonists, useful in addressing disorders associated with CRF or CRF receptors. These novel compounds offer promising avenues for treatment, particularly in mammals and humans.

Career Highlights

Throughout his career, Jeffrey W Corbett has worked with prestigious pharmaceutical companies, including Pfizer Corporation and Pharmacia & Upjohn Company. His experience in these leading firms has enabled him to contribute significantly to pharmaceutical research and development, focusing on innovative treatments that improve patient outcomes.

Collaborations

Corbett's innovations have been further enhanced through collaborations with notable coworkers such as Patrick Robert Verhoest and Robert Louis Hoffman. Their collective expertise has fostered an environment of creativity and advancement, leading to successful patent submissions and impactful inventions in the pharmaceutical landscape.

Conclusion

With a strong foundation in pharmaceutical innovations, Jeffrey W Corbett stands out as a talented inventor. His contributions through various patents are paving the way for new treatments that hold the potential to change lives. As the field of medicine continues to evolve, inventors like Corbett play a crucial role in driving forward the boundaries of medical science and improving the health of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.